Literature DB >> 33672311

Targeting lncRNA H19/miR-29b/COL1A1 Axis Impedes Myofibroblast Activities of Precancerous Oral Submucous Fibrosis.

Cheng-Chia Yu1,2,3, Yi-Wen Liao1,3, Pei-Ling Hsieh4, Yu-Chao Chang2,3.   

Abstract

Oral submucous fibrosis (OSF) is known as a potentially malignant disorder, which may result from chemical irritation due to areca nuts (such as arecoline). Emerging evidence suggests that fibrogenesis and carcinogenesis are regulated by the interaction of long noncoding RNAs (lncRNAs) and microRNAs. Among these regulators, profibrotic lncRNA H19 has been found to be overexpressed in several fibrosis diseases. Here, we examined the expression of H19 in OSF specimens and its functional role in fibrotic buccal mucosal fibroblasts (fBMFs). Our results indicate that the aberrantly overexpressed H19 contributed to higher myofibroblast activities, such as collagen gel contractility and migration ability. We also demonstrated that H19 interacted with miR-29b, which suppressed the direct binding of miR-29b to the 3'-untranslated region of type I collagen (COL1A1). We showed that ectopic expression of miR-29b ameliorated various myofibroblast phenotypes and the expression of α-smooth muscle actin (α-SMA), COL1A1, and fibronectin (FN1) in fBMFs. In OSF tissues, we found that the expression of miR-29b was downregulated and there was a negative correlation between miR-29b and these fibrosis markers. Lastly, we demonstrate that arecoline stimulated the upregulation of H19 through the transforming growth factor (TGF)-β pathway. Altogether, this study suggests that increased TGF-β secretion following areca nut chewing may induce the upregulation of H19, which serves as a natural sponge for miR-29b and impedes its antifibrotic effects.

Entities:  

Keywords:  H19; areca nut; miR-29b; oral submucous fibrosis; type I collagen

Mesh:

Substances:

Year:  2021        PMID: 33672311      PMCID: PMC7926971          DOI: 10.3390/ijms22042216

Source DB:  PubMed          Journal:  Int J Mol Sci        ISSN: 1422-0067            Impact factor:   5.923


  34 in total

Review 1.  Molecular mechanisms of epithelial-mesenchymal transition.

Authors:  Samy Lamouille; Jian Xu; Rik Derynck
Journal:  Nat Rev Mol Cell Biol       Date:  2014-03       Impact factor: 94.444

2.  LncRNA GAS5-AS1 inhibits myofibroblasts activities in oral submucous fibrosis.

Authors:  Che-Yi Lin; Yi-Wen Liao; Pei-Ling Hsieh; Ming-Yi Lu; Chih-Yu Peng; Pei-Ming Chu; Hui-Wen Yang; Yu-Feng Huang; Cheng-Chia Yu; Chuan-Hang Yu
Journal:  J Formos Med Assoc       Date:  2017-12-15       Impact factor: 3.282

3.  miR-29 inhibits bleomycin-induced pulmonary fibrosis in mice.

Authors:  Jun Xiao; Xiao-Ming Meng; Xiao R Huang; Arthur Ck Chung; Yu-Lin Feng; David Sc Hui; Cheuk-Man Yu; Joseph Jy Sung; Hui Y Lan
Journal:  Mol Ther       Date:  2012-03-06       Impact factor: 11.454

4.  Alpha-smooth muscle actin expression upregulates fibroblast contractile activity.

Authors:  B Hinz; G Celetta; J J Tomasek; G Gabbiani; C Chaponnier
Journal:  Mol Biol Cell       Date:  2001-09       Impact factor: 4.138

5.  Hinokitiol ablates myofibroblast activation in precancerous oral submucous fibrosis by targeting Snail.

Authors:  Hui-Wen Yang; Ming-Yi Lu; Yu-Wei Chiu; Yi-Wen Liao; Yu-Feng Huang; Pin Ju Chueh; Pei-Ling Hsieh; Cheng-Chia Yu
Journal:  Environ Toxicol       Date:  2018-01-12       Impact factor: 4.119

6.  Knockdown of Long Noncoding RNA H19 Represses the Progress of Pulmonary Fibrosis through the Transforming Growth Factor β/Smad3 Pathway by Regulating MicroRNA 140.

Authors:  Xi Wang; Zhe Cheng; Lingling Dai; Tianci Jiang; Liuqun Jia; Xiaogang Jing; Lin An; Huan Wang; Meng Liu
Journal:  Mol Cell Biol       Date:  2019-05-28       Impact factor: 4.272

7.  Inhibition of miR-29 by TGF-beta-Smad3 signaling through dual mechanisms promotes transdifferentiation of mouse myoblasts into myofibroblasts.

Authors:  Liang Zhou; Lijun Wang; Leina Lu; Peiyong Jiang; Hao Sun; Huating Wang
Journal:  PLoS One       Date:  2012-03-16       Impact factor: 3.240

8.  Role of Areca Nut Induced TGF-β and Epithelial-Mesenchymal Interaction in the Pathogenesis of Oral Submucous Fibrosis.

Authors:  Ila Pant; Neeraj Kumar; Imran Khan; Somanahalli Girish Rao; Paturu Kondaiah
Journal:  PLoS One       Date:  2015-06-24       Impact factor: 3.240

9.  Arecoline-induced myofibroblast transdifferentiation from human buccal mucosal fibroblasts is mediated by ZEB1.

Authors:  Yu-Chao Chang; Chung-Hung Tsai; You-Liang Lai; Cheng-Chia Yu; Wan-Yu Chi; Jung Jung Li; Wen-Wei Chang
Journal:  J Cell Mol Med       Date:  2014-01-08       Impact factor: 5.310

10.  miR-200b ameliorates myofibroblast transdifferentiation in precancerous oral submucous fibrosis through targeting ZEB2.

Authors:  Yi-Wen Liao; Cheng-Chia Yu; Pei-Ling Hsieh; Yu-Chao Chang
Journal:  J Cell Mol Med       Date:  2018-06-12       Impact factor: 5.310

View more
  4 in total

1.  Fucoidan-Mediated Inhibition of Fibrotic Properties in Oral Submucous Fibrosis via the MEG3/miR-181a/Egr1 Axis.

Authors:  Chih-Yuan Fang; Szu-Han Chen; Chun-Chung Huang; Yi-Wen Liao; Shih-Chi Chao; Cheng-Chia Yu
Journal:  Pharmaceuticals (Basel)       Date:  2022-07-05

Review 2.  The functional roles of microRNAs in the pathogenesis of oral submucous fibrosis.

Authors:  Pei-Ling Hsieh; Szu-Han Chen; Yu-Feng Huang; Ming-Yi Lu; Cheng-Chia Yu
Journal:  J Dent Sci       Date:  2021-08-01       Impact factor: 3.719

3.  Low LINC02147 expression promotes the malignant progression of oral submucous fibrosis.

Authors:  Jun Chen; Wenjie Li; Binjie Liu; Xiaoli Xie
Journal:  BMC Oral Health       Date:  2022-07-29       Impact factor: 3.747

Review 4.  Serum non-coding RNAs for diagnosis and stage of liver fibrosis.

Authors:  Chao Liu; Xueyun Hou; Kaixin Mo; Nannan Li; Cheng An; Guijian Liu; Zongdai Pan
Journal:  J Clin Lab Anal       Date:  2022-08-21       Impact factor: 3.124

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.